Bio
Hari Bhaskaran's journey with RNAs started with ribozymes (catalytic RNAs) almost 20 years ago in the labs of Rick Russell at UT Austin. His PhD work was focused on mechanistic understanding of RNA folding, culminating in a seminal publication in Nature (see Bhaskaran and Russell, 2007). Since then, he has held positions of increasing responsibilities in both academia and industry, with most of those years spent facilitating transition of mRNA therapeutics successfully into the clinic. His roles have led him to produce innovative mRNA construct designs, create scale-up techniques for manufacturing and improve process development for purification and analytics. He is the author of several publications and industry patents.
Career
|
Cisterna Biologics - founderHigh quality mRNA for therapeutic application. |